Color blindness, a subject of eugenics in 20th century Japanese society, and the more desirable concept of "color vision diversity" proposed for the 21st century.Hiroto KAWABATA In the 20th century, people with congenital color vision deficiency (CVD) were subjected to eugenic ideology and suffered genetic discrimination in Japan. This paper first suggests the involvement of science (so-called eugenics) and medicine (ophthalmology) in the background. The Japanese Society of Race Hygiene, founded in 1930, was keen to introduce eugenics into Japan and they used CVD as a prime example when promoting their idea. One reason was that CVD could be easily detected by the Ishihara plates developed by a Japanese ophthalmologist, and screening tests for all children were already being conducted nationwide. The Society have parted ways with eugenics since 1958. Epidemiology and public health thinking played a major role in their change of policy.Japanese genetic scientists in the 21st century, reflecting on the past, argued that it is more appropriate to understand CVD as a "normal" genetic polymorphism rather than an "abnormality". Based on this idea, they proposed the concept of "color vision diversity".However, even now, Japanese society has not dispelled the notion that CVD is genetically inferior. One reason is that ophthalmologists, who are considered authorities on color vision, cling to the idea that CVD is abnormal. Redesign of testing and diagnosis is also important, as studies have accumulated showing that testing with the Ishihara plates is not accurate. Evidence-based epidemiology and public health approaches may be useful here as well.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.